Skip to main navigation Skip to search Skip to main content

Levetiracetam (Keppra) in the Treatment of Choreiform Movements in Huntington's Disease

  • Theresa A. Zesiewicz
  • , Kelly L. Sullivan
  • , R. A. Hauser
  • , R. Behrouz
  • , J. R. Sanchez-Ramos
  • University of South Florida

Research output: Contribution to conferencePresentation

Abstract

This presentation was given at the American Academy of Neurology Annual Meeting.
Original languageAmerican English
StatePublished - Apr 12 2005
EventAmerican Academy of Neurology Annual Meeting (AAN) -
Duration: Apr 23 2018 → …

Conference

ConferenceAmerican Academy of Neurology Annual Meeting (AAN)
Period04/23/18 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Public Health
  • Epidemiology

Keywords

  • Choreiform
  • Huntington's disease
  • Keppra
  • Levetiracetam
  • Movements
  • Treatment

Fingerprint

Dive into the research topics of 'Levetiracetam (Keppra) in the Treatment of Choreiform Movements in Huntington's Disease'. Together they form a unique fingerprint.

Cite this